drugset / Trial / NCT06391931

A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery

NCT06391931

Phase 3 Completed 190 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicenter, open, controlled, Phase III clinical study to evaluate the efficacy and safety of Cipepofol injection for general anesthesia in pediatric patients undergoing elective surgery

Timeline

Start
2024-04-07
Primary completion
2024-11-06
Completion
2024-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.8 mg/kg
Comparator Propofol Small molecule 5 mg/kg

Indications

No indication recorded.